雖然還在臨床二期實驗, 但能有降低武漢肺炎病毒量的藥物總是好事一樁~

"With vaccine rollout in some countries going well, there are questions as to whether we need COVID drugs. Due to the explosion of the new and more transmissible delta variant, which will likely be the dominant strain before year-end globally—and its capacity to evade some vaccine immunity (and the fact that most of the world still isn’t anywhere near herd immunity)—demand for antivirals will likely remain high for some time."

https://www.fiercebiotech.com/biotech/roche-and-atea-s-small-early-data-peek-sees-experimental-covid-drug-slash-viral-load